MUMBAI, 19 JAN 2023: People suffering from cardiac problems can look forward to substantial savings in their healthcare budget. Several domestic companies including Glenmark and Lupin have launched generic versions of blockbuster cardiology drug Valsartan at a fraction of the pri......
View Details

Related News

• Indian Patent Office to hear objections on Gilead's HIV drug patent claims (18-09-2024)

---

• CDSCO revises guidance document for functions & responsibilities of zonal, sub-zonal & port offices (18-09-2024)

---

• India exported drugs and pharma worth $11.9 bn in April-August 2024 (18-09-2024)

---

• US FDA releases draft guidance on oncology multiregional clinical trials (18-09-2024)

---

• Narcotists raid in UP-Uttarakhand, fake medicines worth three crores, machines worth eight crores seized, five arrested (18-09-2024)

---

• DCC recommends making Sugam portal database of all products with brand names (17-09-2024)

---

• CDSCO releases draft guidelines on good clinical practices for consultation (17-09-2024)

---

• One-third of India’s 30 lakh sepsis deaths linked to antimicrobial resistance (17-09-2024)

---

• Pharmacist practicing without degree, 35 types of medicines and surgical equipments seized (17-09-2024)

---

• CDSCO to switch Form 44 submission online (16-09-2024)

---